Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-20-059138
Filing Date
2020-05-11
Accepted
2020-05-11 07:56:12
Documents
2
Effectiveness Date
2020-05-11

Document Format Files

Seq Description Document Type Size
1 DEFA14A a20-19215_2defa14a.htm DEFA14A 49656
2 GRAPHIC g192152bei001.jpg GRAPHIC 5800
  Complete submission text file 0001104659-20-059138.txt   58966
Mailing Address 375 PHEASANT RUN NEWTOWN PA 18940
Business Address 375 PHEASANT RUN NEWTOWN PA 18940 267-759-3681
Onconova Therapeutics, Inc. (Filer) CIK: 0001130598 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36020 | Film No.: 20862659
SIC: 2834 Pharmaceutical Preparations